Clinical Cardiology Alert – May 1, 2014
May 1, 2014
View Issues
-
Metoprolol Prior to Primary PCI: An Old Drug Gets Some New Data
Beta-blockers have long been considered a cornerstone of therapy for patients with acute myocardial infarction (MI). -
Accuracy of ECG Localization of the Culprit Artery in STEMI
The early ECGs are the mainstay of predicting the culprit coronary artery in ST-segment elevation myocardial infarction (STEMI) -
Beta-Blockers in CAD Patients Undergoing Non-Cardiac Surgery
Recent controversy has erupted concerning the use of prophylactic beta-blockers in patients with known or suspected coronary artery disease (CAD) undergoing non-cardiac surgery. -
Pharmacologic Rate Control in Atrial Fibrillation
Current guidelines recommend monotherapy with either beta-blockers or rate lowering calcium blockers for heart rate control in patients with permanent atrial fibrillation (AF). -
Should Dialysis Patients with Atrial Fibrillation Be Treated with Warfarin?
This was a retrospective cohort study from Quebec and Ontario, Canada, examining patients ≥ 65 years of age admitted to a hospital with a diagnosis of atrial fibrillation (AF) between 1998 and 2007. -
SYMPLICITY HTN-3 Tempers Enthusiasm for Renal Denervation in the United States
Resistant hypertension, defined as a systolic blood pressure (BP) that remains above goal despite treatment with at least three complementary antihypertensive agents of different classes at maximally tolerated doses, has become an increasingly common diagnosis in recent years.